MeadowBrook Investment Advisors LLC Makes New Investment in Oracle Co. (NYSE:ORCL)

MeadowBrook Investment Advisors LLC purchased a new position in Oracle Co. (NYSE:ORCL) in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 537 shares of the enterprise software provider’s stock, valued at approximately $57,000.

Other institutional investors have also added to or reduced their stakes in the company. Orion Capital Management LLC acquired a new stake in shares of Oracle during the third quarter worth about $25,000. Ritter Daniher Financial Advisory LLC DE increased its position in shares of Oracle by 298.4% in the third quarter. Ritter Daniher Financial Advisory LLC DE now owns 243 shares of the enterprise software provider’s stock valued at $26,000 after buying an additional 182 shares in the last quarter. Spartan Planning & Wealth Management purchased a new stake in shares of Oracle during the third quarter worth approximately $27,000. Cornerstone Planning Group LLC increased its position in shares of Oracle by 1,268.0% during the third quarter. Cornerstone Planning Group LLC now owns 342 shares of the enterprise software provider’s stock worth $36,000 after purchasing an additional 317 shares in the last quarter. Finally, BOK Financial Private Wealth Inc. boosted its stake in Oracle by 139.4% during the fourth quarter. BOK Financial Private Wealth Inc. now owns 371 shares of the enterprise software provider’s stock worth $39,000 after buying an additional 216 shares during the last quarter. Institutional investors and hedge funds own 42.44% of the company’s stock.

Oracle Stock Performance

ORCL traded up $2.54 during trading on Monday, hitting $118.34. 5,301,334 shares of the stock were exchanged, compared to its average volume of 8,261,409. The firm has a market capitalization of $325.26 billion, a P/E ratio of 31.22, a PEG ratio of 2.32 and a beta of 1.03. Oracle Co. has a 1-year low of $96.10 and a 1-year high of $132.77. The stock has a fifty day moving average price of $120.06 and a two-hundred day moving average price of $113.46. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 13.34.

Oracle (NYSE:ORCL) last announced its earnings results on Monday, March 11th. The enterprise software provider reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.37 by $0.04. Oracle had a return on equity of 336.11% and a net margin of 20.27%. The company had revenue of $13.28 billion for the quarter, compared to the consensus estimate of $13.29 billion. During the same period last year, the business posted $0.96 EPS. The company’s revenue was up 7.1% on a year-over-year basis. As a group, sell-side analysts predict that Oracle Co. will post 4.44 earnings per share for the current year.

Oracle Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Wednesday, April 24th. Shareholders of record on Wednesday, April 10th were paid a $0.40 dividend. The ex-dividend date was Tuesday, April 9th. This represents a $1.60 annualized dividend and a dividend yield of 1.35%. Oracle’s dividend payout ratio (DPR) is currently 42.22%.

Insider Buying and Selling at Oracle

In other Oracle news, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction that occurred on Friday, May 3rd. The stock was sold at an average price of $116.00, for a total value of $2,320,000.00. Following the transaction, the director now directly owns 17,836 shares in the company, valued at approximately $2,068,976. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, Director George H. Conrades sold 25,000 shares of Oracle stock in a transaction that occurred on Wednesday, May 1st. The stock was sold at an average price of $116.13, for a total value of $2,903,250.00. Following the sale, the director now directly owns 17,836 shares in the company, valued at $2,071,294.68. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the completion of the sale, the director now owns 17,836 shares in the company, valued at $2,068,976. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 835,000 shares of company stock worth $105,189,850. 42.80% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on ORCL shares. The Goldman Sachs Group boosted their price objective on Oracle from $115.00 to $130.00 and gave the stock a “neutral” rating in a research note on Wednesday, March 13th. William Blair raised Oracle from a “market perform” rating to an “outperform” rating in a research note on Tuesday, March 12th. Argus raised Oracle from a “hold” rating to a “buy” rating in a research note on Thursday, March 14th. StockNews.com lowered Oracle from a “buy” rating to a “hold” rating in a research note on Wednesday, May 1st. Finally, Oppenheimer assumed coverage on Oracle in a research note on Thursday, April 18th. They issued a “market perform” rating on the stock. Eleven research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $130.76.

About Oracle

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.